Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Matthew J. Sinback

Attorney

Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX

Matthew J. Sinback

Attorney

Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX
Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX

Matt Sinback's practice focuses on antitrust counseling and litigation. Matt also has experience in general business litigation, agency representation of utilities, internal investigations and human rights litigation.

  • Antitrust & Trade Practices – Matt regularly counsels clients on antitrust issues arising in significant mergers and acquisitions, including Hart-Scott-Rodino Act compliance, the exchange of sensitive information during due diligence, integration planning and preparation for potential investigation or intervention by the Federal Trade Commission or Department of Justice. Matt has provided advice on HSR Act compliance in numerous transactions, including analysis of whether premerger notification is required and preparation of the premerger notification form required by the Act. In addition, Matt has experience in assisting clients with creating or improving their antitrust compliance policies and procedures.
  • Healthcare – Matt has provided antitrust counseling to companies in the healthcare industry, including advising on antitrust compliance programs, the antitrust implications of proposed conduct and antitrust issues associated with significant mergers.
  • Administrative & Regulatory Proceedings – Matt has served on the trial counsel team in utility ratemaking proceedings before the Tennessee Regulatory Authority.

Memberships

American Bar Association — Section of Antitrust Law: Mergers & Acquisitions Committee, Compliance & Ethics Committee, Health Care and Pharmaceuticals Committee; Section of Litigation

American Health Lawyers Association (AHLA) — Antitrust Practice Group

Tennessee Bar Association

News

View More

Representative Experience

View More

Media Mentions

View More

Accolades

American Criminal Law Review — Articles and Notes Editor

Phi Beta Kappa

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.